Annual Drug Patent Expirations for PATANASE Patanase is a drug marketed by Novartis and is included in one NDA. It is available from two suppliers. There are two patents protecting…
The post New patent expiration for Novartis drug PATANASE appeared fir…
New patent expiration for Novartis drug PATANASE Read Post »
DEXILANT SOLUTAB (dexlansoprazole) Takeda pharms usa Patent: 6,664,276 Expiration: Jul 30, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirati…
Drug Patent Expirations for the Week of July 30, 2023 Read Post »
Annual Drug Patent Expirations for ONGLYZA Onglyza is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from two suppliers. There are two patents…
The post New patent expiration for Astrazeneca Ab drug ONGLYZA appeared first…
New patent expiration for Astrazeneca Ab drug ONGLYZA Read Post »
Annual Drug Patent Expirations for ONGLYZA Onglyza is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from two suppliers. There are two patents…
The post New patent expiration for Astrazeneca Ab drug ONGLYZA appeared first…
New patent expiration for Astrazeneca Ab drug ONGLYZA Read Post »
Annual Drug Patent Expirations for KOMBIGLYZE+XR Kombiglyze Xr is a drug marketed by Astrazeneca Ab and is included in one NDA. It is available from one supplier. There are three…
The post New patent expiration for Astrazeneca Ab drug KOMBIGLYZE XR app…
New patent expiration for Astrazeneca Ab drug KOMBIGLYZE XR Read Post »
Annual Drug Patent Expirations for QTERN Qtern is a drug marketed by Astrazeneca Ab and is included in two NDAs. It is available from one supplier. There are nine patents…
The post New patent expiration for Astrazeneca Ab drug QTERN appeared first on D…
New patent expiration for Astrazeneca Ab drug QTERN Read Post »
Annual Drug Patent Expirations for QTERNMET+XR Qternmet Xr is a drug marketed by Astrazeneca Ab and is included in one NDA. There are seven patents protecting this drug. Drug patent…
The post New patent expiration for Astrazeneca Ab drug QTERNMET XR ap…
New patent expiration for Astrazeneca Ab drug QTERNMET XR Read Post »
Annual Drug Patent Expirations for QTERNMET+XR Qternmet Xr is a drug marketed by Astrazeneca Ab and is included in one NDA. There are seven patents protecting this drug. Drug patent…
The post New patent expiration for Astrazeneca Ab drug QTERNMET XR ap…
New patent expiration for Astrazeneca Ab drug QTERNMET XR Read Post »
Annual Drug Patent Expirations for DEXILANT+SOLUTAB Dexilant Solutab is a drug marketed by Takeda Pharms Usa and is included in one NDA. There are seven patents protecting this drug. Drug…
The post New patent expiration for Takeda Pharms drug DEXILANT …
New patent expiration for Takeda Pharms drug DEXILANT SOLUTAB Read Post »
DEXILANT SOLUTAB (dexlansoprazole) Takeda pharms usa Patent: 6,664,276 Expiration: Jul 30, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact…
The post Drug Patent Expirati…
Drug Patent Expirations for the Week of July 30, 2023 Read Post »